Drug Type Therapeutic radiopharmaceuticals |
Synonyms 3D 1025, 3D1025 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metastatic castration-resistant prostate cancer | Preclinical | United States | 01 Nov 2025 | |
| Metastatic castration-resistant prostate cancer | Preclinical | China | 01 Nov 2025 |





